跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI
Authorized
STANDARD
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e8ac263e290beae2
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
e8ac263e290beae2
Drug Approval Canada Name
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI
Product Name
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI
Status
Marketed
Status Date
2022-05-03
Original Market Date
2022-05-03
Din
02517760
Drug Class
Human
Dosage Form
Capsule , Cream
Route Of Administration
Oral , Topical
Schedule
OTC
Ahfs
84:04.08.08
Atc Original
G01AF02 CLOTRIMAZOLE
Atc Name
g 01 af 02
Aig Number
0252465002
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
CLOTRIMAZOLE
2 %
FLUCONAZOLE
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e8ac263e290beae2
Type
Standard
Back to Health Canada Approvals